CluePoints is proud to collaborate with a number of strategic partners who have been instrumental in supporting the organization’s vision of improving data quality and integrity, reducing regulatory submission risk and lowering overall development costs.


With more than 380,000 customers—including 100 of the Fortune 100—and with deployments across a wide variety of industries in more than 145 countries around the globe, Oracle offers an optimized and fully integrated stack of business hardware and software systems.


Bracket is a recognized leader in Rater Training and Quality Assurance. This exclusive partnership will see CluePoints’ RBM software offered in combination with Bracket’s Blinded Data Analytics and Rater Training and Quality Assurance oversight program for psychiatry and neurology trials. Bringing together CluePoints’ and Bracket’s expertise and solutions will enhance the impact of the services that each company delivers to sponsors, improving the integrity and quality of clinical data.

As the EDC specialists OmniComm understands the power that an information-driven clinical enterprise can bring to your clinical research organization. OmniComm is the only company that provides our clients with a choice of best-of-breed EDC platforms that are purpose-built for their unique clinical research environments – Early Phase, Late Phase, Phase I-IV, device trials, Investigator Initiated.


Widler & Schiemann’s experts work with clients to identify how workflows, processes and systems need to be adapted to support more targeted approaches to monitoring in clinical trials. The company’s services complement CluePoints’ Central Statistical Monitoring (CSM) software, which provides an agnostic approach to RBM by using statistical methodology to identify unexpected patterns in trial databases and focus monitoring efforts.


GSK Vaccines business is one of the largest in the world, with over 1.1 billion doses distributed to paediatric and adult patients in 173 countries to prevent a range of infectious diseases. GSK have partnered with CluePoints® to assist in the development of the SMART™ engine by providing numerous active clinical trial data sets to use for pilot projects and in order to perfect the matrix of statistical algorithms used in the product.


IDDI (International Drug Development Institute) has been providing eClinical and Biostatistical services provider for clinical trials since 1991. IDDI has been instrumental in developing the SMART™ engine that drives the complex statistical algorithms within the CluePoints® solution.


The Institut De Statistique, part of the Université Catholique de Louvain in Belgium, was founded in 1992 and coordinates all the teaching and research activities within the university in the areas of biostatistics, mathematical statistics and quantitative analysis of insurance and financial risks. This research group has been one of the academic partners involved in the development of the SMART™ engine.


IRIDIA is the Artificial Intelligence research laboratory of the Université Libre de Bruxelles. It is deeply involved in theoretical and applied research in computational intelligence. Its major domains of competence are swarm intelligence, metaheuristics for solving space optimization problems, the foundational study of biological networks, and business intelligence applications. IRIDIA has been an academic partner in the development of the SMART™ engine.